Rosmarinic Acid Inhibits Mitochondrial Damage by Alleviating Unfolded Protein Response

Guoen Cai1, Fabin Lin1,2, Dihang Wu1,2

  • 1Department of Neurology, Fujian Medical University Union Hospital, Fujian Key Laboratory of Molecular Neurology, Institute of Clinical Neurology, Institute of Neuroscience, Fujian Medical University, Fuzhou, China.

Insights

Rosmarinic acid (RA) protects against Parkinson's disease by preventing mitochondrial damage. RA alleviates the mitochondrial unfolded protein response (mtUPR), safeguarding dopaminergic neurons from MPTP-induced injury.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pharmacology

Background:

  • Mitochondria are crucial for cellular functions, and their dysfunction is linked to Parkinson's disease (PD) via the mitochondrial unfolded protein response (mtUPR).
  • 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is a neurotoxin used to model PD, causing mitochondrial damage in dopaminergic neurons.

Purpose of the Study:

  • To investigate the protective effects of Rosmarinic acid (RA) against MPTP-induced mitochondrial damage in Parkinson's disease.
  • To elucidate the underlying mechanism involving the mitochondrial unfolded protein response (mtUPR).

Main Methods:

  • MPTP mouse model of Parkinson's disease and SH-SY5Y neuroblastoma cells were used.
  • Mice and cells were pretreated with Rosmarinic acid (RA) before MPTP exposure.
  • Evaluated motor function, dopaminergic neuronal survival, cell viability, oxidative stress, and expression of key mtUPR-related genes (HSPA9, HSPE1, CLPP, LONP1, SIRT4).

Main Results:

  • RA pretreatment significantly reduced motor impairments and dopaminergic neuronal loss in MPTP-injected mice.
  • RA protected SH-SY5Y cells from MPTP-induced loss of viability, morphological damage, and oxidative stress.
  • RA suppressed MPTP-induced mtUPR and downregulated the expression of HSPA9, HSPE1, CLPP, LONP1, and SIRT4, preventing mitochondrial dysfunction.

Conclusions:

  • Rosmarinic acid demonstrates significant neuroprotective effects against MPTP-induced Parkinson's disease pathology.
  • RA alleviates mitochondrial damage by inhibiting the mitochondrial unfolded protein response (mtUPR).
  • These findings suggest RA as a potential therapeutic agent for Parkinson's disease by targeting mitochondrial dysfunction.

Related Concept Videos

The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
5.1K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.1K
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
17.5K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
4.6K
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
12.5K